U01CA244452
Cooperative Agreement
Overview
Grant Description
Mechanisms of exosome driven immunoregulation of cancer progression.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
San Francisco,
California
94143
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/24 to 08/31/25 and the total obligations have increased 5% from $3,950,956 to $4,146,592.
San Francisco Regents Of The University Of California was awarded
Mechanisms of Exosome Driven Immunoregulation of Cancer Progression
Cooperative Agreement U01CA244452
worth $4,146,592
from the National Institute of Allergy and Infectious Diseases in September 2019 with work to be completed primarily in San Francisco California United States.
The grant
has a duration of 6 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 8/5/24
Period of Performance
9/23/19
Start Date
8/31/25
End Date
Funding Split
$4.1M
Federal Obligation
$0.0
Non-Federal Obligation
$4.1M
Total Obligated
Activity Timeline
Transaction History
Modifications to U01CA244452
Additional Detail
Award ID FAIN
U01CA244452
SAI Number
U01CA244452-4172008711
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
KMH5K9V7S518
Awardee CAGE
4B560
Performance District
CA-11
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $7,901,912 | 99% |
Modified: 8/5/24